Levodopa, also known as L-DOPA, is a precursor to dopamine, a neurotransmitter that is deficient in the brains of individuals with Parkinson's disease. Administered orally, it crosses the blood-brain barrier and is converted into dopamine in the brain, thus alleviating the motor symptoms associated with dopamine deficiency.
